Magnetic resonance spectroscopy as an imaging tool for cancer: A review of the literature

Naishadh Shah, Ayesha Sattar, Michael Benanti, Scott Hollander, Lanna Cheuck

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Objectives: To review the use of magnetic resonance spectroscopy (MRS) as a clinical tool in the identification of cerebral neoplasia type and grade, as well as neoplasia in the prostate, colon, breast, cervix, pancreas, and esophagus. Also, to review how clinicians are using MRS for surgical planning and longitudinal evaluation of tumors after treatment. Data Sources: Studies and clinical case reports published within the previous 10 years, targeting publications in radiology and oncology journals within the previous 3 years. Sources identified via MEDLINE and PubMed databases. Study Selection: Studies that contrasted MRS with conventional diagnostic and prognostic methods were considered to yield the most relevant data for this review. Studies discussing cancer staging and grading were also examined to help determine clinical significance of MRS. Data Syntheses: A review of the literature reveals that, although MRS has mainly been used in diagnostics and tumor evaluation for brain cancer, it is becoming an increasingly important adjunct to conventional diagnostic and monitoring procedures for cancer of the prostate, colon, breast, cervix, pancreas, and esophagus. Conclusions: The clinical usefulness of MRS has yet to be fully substantiated. As MRS availability and access increases, appropriate evaluations of its strengths and weaknesses will be made. The authors conclude that research to date and primary observation indicate that MRS is a promising clinical tool for oncologic management of patients.

Original languageEnglish (US)
Pages (from-to)23-27
Number of pages5
JournalJournal of the American Osteopathic Association
Volume106
Issue number1
StatePublished - Jan 2006
Externally publishedYes

Fingerprint

Magnetic Resonance Spectroscopy
Neoplasms
Cervix Uteri
Esophagus
Pancreas
Breast
Neoplasm Staging
Information Storage and Retrieval
PubMed
Radiology
MEDLINE
Brain Neoplasms
Colonic Neoplasms
Publications
Prostate
Prostatic Neoplasms
Colon
Observation
Databases
Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Magnetic resonance spectroscopy as an imaging tool for cancer : A review of the literature. / Shah, Naishadh; Sattar, Ayesha; Benanti, Michael; Hollander, Scott; Cheuck, Lanna.

In: Journal of the American Osteopathic Association, Vol. 106, No. 1, 01.2006, p. 23-27.

Research output: Contribution to journalArticle

Shah, N, Sattar, A, Benanti, M, Hollander, S & Cheuck, L 2006, 'Magnetic resonance spectroscopy as an imaging tool for cancer: A review of the literature', Journal of the American Osteopathic Association, vol. 106, no. 1, pp. 23-27.
Shah, Naishadh ; Sattar, Ayesha ; Benanti, Michael ; Hollander, Scott ; Cheuck, Lanna. / Magnetic resonance spectroscopy as an imaging tool for cancer : A review of the literature. In: Journal of the American Osteopathic Association. 2006 ; Vol. 106, No. 1. pp. 23-27.
@article{60c00608aa9844a3a7602d17eb044c10,
title = "Magnetic resonance spectroscopy as an imaging tool for cancer: A review of the literature",
abstract = "Objectives: To review the use of magnetic resonance spectroscopy (MRS) as a clinical tool in the identification of cerebral neoplasia type and grade, as well as neoplasia in the prostate, colon, breast, cervix, pancreas, and esophagus. Also, to review how clinicians are using MRS for surgical planning and longitudinal evaluation of tumors after treatment. Data Sources: Studies and clinical case reports published within the previous 10 years, targeting publications in radiology and oncology journals within the previous 3 years. Sources identified via MEDLINE and PubMed databases. Study Selection: Studies that contrasted MRS with conventional diagnostic and prognostic methods were considered to yield the most relevant data for this review. Studies discussing cancer staging and grading were also examined to help determine clinical significance of MRS. Data Syntheses: A review of the literature reveals that, although MRS has mainly been used in diagnostics and tumor evaluation for brain cancer, it is becoming an increasingly important adjunct to conventional diagnostic and monitoring procedures for cancer of the prostate, colon, breast, cervix, pancreas, and esophagus. Conclusions: The clinical usefulness of MRS has yet to be fully substantiated. As MRS availability and access increases, appropriate evaluations of its strengths and weaknesses will be made. The authors conclude that research to date and primary observation indicate that MRS is a promising clinical tool for oncologic management of patients.",
author = "Naishadh Shah and Ayesha Sattar and Michael Benanti and Scott Hollander and Lanna Cheuck",
year = "2006",
month = "1",
language = "English (US)",
volume = "106",
pages = "23--27",
journal = "The Journal of the American Osteopathic Association",
issn = "0098-6151",
publisher = "American Osteopathic Association",
number = "1",

}

TY - JOUR

T1 - Magnetic resonance spectroscopy as an imaging tool for cancer

T2 - A review of the literature

AU - Shah, Naishadh

AU - Sattar, Ayesha

AU - Benanti, Michael

AU - Hollander, Scott

AU - Cheuck, Lanna

PY - 2006/1

Y1 - 2006/1

N2 - Objectives: To review the use of magnetic resonance spectroscopy (MRS) as a clinical tool in the identification of cerebral neoplasia type and grade, as well as neoplasia in the prostate, colon, breast, cervix, pancreas, and esophagus. Also, to review how clinicians are using MRS for surgical planning and longitudinal evaluation of tumors after treatment. Data Sources: Studies and clinical case reports published within the previous 10 years, targeting publications in radiology and oncology journals within the previous 3 years. Sources identified via MEDLINE and PubMed databases. Study Selection: Studies that contrasted MRS with conventional diagnostic and prognostic methods were considered to yield the most relevant data for this review. Studies discussing cancer staging and grading were also examined to help determine clinical significance of MRS. Data Syntheses: A review of the literature reveals that, although MRS has mainly been used in diagnostics and tumor evaluation for brain cancer, it is becoming an increasingly important adjunct to conventional diagnostic and monitoring procedures for cancer of the prostate, colon, breast, cervix, pancreas, and esophagus. Conclusions: The clinical usefulness of MRS has yet to be fully substantiated. As MRS availability and access increases, appropriate evaluations of its strengths and weaknesses will be made. The authors conclude that research to date and primary observation indicate that MRS is a promising clinical tool for oncologic management of patients.

AB - Objectives: To review the use of magnetic resonance spectroscopy (MRS) as a clinical tool in the identification of cerebral neoplasia type and grade, as well as neoplasia in the prostate, colon, breast, cervix, pancreas, and esophagus. Also, to review how clinicians are using MRS for surgical planning and longitudinal evaluation of tumors after treatment. Data Sources: Studies and clinical case reports published within the previous 10 years, targeting publications in radiology and oncology journals within the previous 3 years. Sources identified via MEDLINE and PubMed databases. Study Selection: Studies that contrasted MRS with conventional diagnostic and prognostic methods were considered to yield the most relevant data for this review. Studies discussing cancer staging and grading were also examined to help determine clinical significance of MRS. Data Syntheses: A review of the literature reveals that, although MRS has mainly been used in diagnostics and tumor evaluation for brain cancer, it is becoming an increasingly important adjunct to conventional diagnostic and monitoring procedures for cancer of the prostate, colon, breast, cervix, pancreas, and esophagus. Conclusions: The clinical usefulness of MRS has yet to be fully substantiated. As MRS availability and access increases, appropriate evaluations of its strengths and weaknesses will be made. The authors conclude that research to date and primary observation indicate that MRS is a promising clinical tool for oncologic management of patients.

UR - http://www.scopus.com/inward/record.url?scp=31544473124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31544473124&partnerID=8YFLogxK

M3 - Article

C2 - 16428685

AN - SCOPUS:31544473124

VL - 106

SP - 23

EP - 27

JO - The Journal of the American Osteopathic Association

JF - The Journal of the American Osteopathic Association

SN - 0098-6151

IS - 1

ER -